- Home
- LITM vs RADX Comparison
LITM vs RADX Comparison
Compare LITM & RADX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LITM
- RADX
- Stock Information
- Founded
- LITM 2018
- RADX 2021
- Country
- LITM Canada
- RADX Australia
- Employees
- LITM N/A
- RADX N/A
- Industry
- LITM Other Metals and Minerals
- RADX
- Sector
- LITM Basic Materials
- RADX
- Exchange
- LITM Nasdaq
- RADX NYSE
- Market Cap
- LITM 26.7M
- RADX 32.5M
- IPO Year
- LITM 2021
- RADX N/A
- Fundamental
- Price
- LITM $3.97
- RADX $4.25
- Analyst Decision
- LITM
- RADX Strong Buy
- Analyst Count
- LITM 0
- RADX 2
- Target Price
- LITM N/A
- RADX $13.50
- AVG Volume (30 Days)
- LITM 290.0K
- RADX 22.4K
- Earning Date
- LITM 04-10-2025
- RADX 02-26-2025
- Dividend Yield
- LITM N/A
- RADX N/A
- EPS Growth
- LITM N/A
- RADX N/A
- EPS
- LITM N/A
- RADX N/A
- Revenue
- LITM N/A
- RADX $204,609.00
- Revenue This Year
- LITM N/A
- RADX N/A
- Revenue Next Year
- LITM N/A
- RADX N/A
- P/E Ratio
- LITM N/A
- RADX N/A
- Revenue Growth
- LITM N/A
- RADX N/A
- 52 Week Low
- LITM $1.98
- RADX $3.50
- 52 Week High
- LITM $24.44
- RADX $50.82
- Technical
- Relative Strength Index (RSI)
- LITM 54.70
- RADX N/A
- Support Level
- LITM $3.70
- RADX N/A
- Resistance Level
- LITM $4.32
- RADX N/A
- Average True Range (ATR)
- LITM 0.29
- RADX 0.00
- MACD
- LITM 0.07
- RADX 0.00
- Stochastic Oscillator
- LITM 67.23
- RADX 0.00
About LITM Snow Lake Resources Ltd.
Snow Lake Resources Ltd is a Canadian clean energy exploration company with a world-wide portfolio of clean energy mineral projects comprised of two uranium projects and two hard rock lithium projects. Its Projects include: The Black Lake Uranium Project, the Engo Valley Uranium Project, The Shatford Lake Project, and the Snow Lake Lithium Project.
About RADX RADIOPHARM THERANOSTICS LIMITED SPON ADS EACH REP 300 ORD
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.